Skip to content
  • About Us
  • Pipeline
  • Publications
  • Careers
  • Investors
  • Careers
  • CLINICALTRIALS.GOV
  • The Crestone Study
  • Newsroom

    LifeSci Partners Precision Oncology Day 2021

    February 17, 2021June 30, 2021
    by Elevation Oncology
    Corporate Overview

    Corporate Overview

    Presenter: Shawn Leland
    Date/Time: February 17, 2021 3:00 PM EST
    Access: Free with Registration. Recording will be available for 30 days following presentation.

    Access Presentation
    Share
    Other Related Resources
    July 21, 2020February 22, 2021

    Newsroom

    Elevation Oncology Emerges from Stealth with $32.5M Series A to Develop Precision Medicines for Tumors Harboring Rare Genetic Driver Alterations Read More
    September 30, 2020April 8, 2021

    Press Releases

    Elevation Oncology and US Oncology Research Announce Collaboration to Expand Genomic Testing of Solid Tumors and Local Site Activation in Support of the Phase 2 CRESTONE Study Read More
    October 26, 2020March 3, 2021

    Newsroom

    Elevation Oncology Announces the Presentation of Preclinical Data on the Specific Inhibition of HER3 to Block NRG1 Fusion Signaling Read More
    November 18, 2020March 3, 2021

    Newsroom

    Elevation Oncology Announces $65M Series B Financing and Promotion of Founder Shawn M. Leland to Chief Executive Officer Read More
    January 6, 2021March 3, 2021

    Newsroom

    Elevation Oncology to Present at the 39th Annual J.P. Morgan Healthcare Conference Read More
    March 16, 2021July 13, 2021

    Newsroom

    Elevation Oncology and NeoGenomics Announce Collaboration to Expand Genomic Testing for NRG1 Fusions Across Solid Tumors in Support of the Phase 2 CRESTONE Study Read More
    Newsroom
    • Our Focus
    • About Us
    • Careers
    • Contact
    • Investors
    • Terms
    • Privacy
    • ClinicalTrials.gov
    • The Crestone Study